Pfizer asks FDA to license COVID-19 antiviral tablet

featured image

Pfizer’s antiviral tablet, utilized to deal with unvaccinated individuals with COVID-19, is the 2nd COVID-19 tablet the FDA is thinking about, consisting of a comparable drug from Merck.

SEE FULL EPISODES OF WORLD NEWS TONIGHT:
https://abc.com/shows/world-news-tonight

ENJOY WORLD NEWS TONIGHT ON HULU:
https://bit.ly/3iQLwPp

#WorldNewsTonight #Covid-19 #FDA #VaccinePill.

https://covid19globalcases.com/pfizer-asks-fda-to-license-covid-19-antiviral-tablet/

Comments